Account
Articles
21.05.2024
How are local markets adapting their HTA evaluatio...

Our experts analyse how local European markets are integrating the EU HTA outputs into national proc...

Read more
Articles
15.05.2024
Navigating the new EU HTA regulation: organisation...

Our latest article summarises the key changes to be aware of for the upcoming EU HTA, as well as imp...

Read more
Webinar
10.05.2024
EU HTA: moving from strategy to action

Remap Consulting guides participants through the intricacies of incorporating EU HTA considerations ...

Read more
Insider Insights
07.03.2024
EU releases draft act on Joint Clinical Assessment...

Consultation launched on EU draft Regulation for joint clinical assessments, seeking feedback to imp...

Read more
Insider Insights
22.02.2024
Nordic Pharmaceutical Forum develops new website t...

New website provides regular updates on NLF's work, addresses challenges, and showcases collaboratio...

Read more
Articles
24.01.2024
What are the 5 Pricing & Market Access trends...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
Articles
13.12.2023
Reflecting on the Pricing & Market Access tre...

Back in January this year, we summarised the key trends our market access experts believed would dom...

Read more
Articles
01.11.2023
World Orphan Drug Congress Europe 2023 REPORT

We summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H...

Read more
Publications
25.10.2023
ISPOR Europe 2023: How Aware Are Biotech and Pharm...

Our research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in...

Read more
Articles
08.08.2023
How to get payer scientific advice between now and...

Our market access experts provide an overview of how to get payer scientific advice between Septembe...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.